# Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab

> **NCT07041268** · PHASE2 · RECRUITING · sponsor: **Pirogov Russian National Research Medical University** · enrollment: 116 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** rituximab

## Key facts

- **NCT ID:** NCT07041268
- **Lead sponsor:** Pirogov Russian National Research Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-19
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07041268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07041268, "Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07041268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*